NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

TransMedics Group Inc (TMDX) stock saw a modest uptick, ending the day at $67.03 which represents a slight increase of $5.96 or 9.76% from the prior close of $61.07. The stock opened at $61.47 and ...

New York, New York-- (Newsfile Corp. - January 29, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...

Check the time stamp on this data. Updated AI-Generated Signals for Transmedics Group Inc. (TMDX) available here: TMDX. Type ...

TransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion ...

Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...

TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.

View TransMedics Group, Inc. (TMDX) current and estimated P/E ratio data provided by Seeking Alpha.

JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...

TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average annual return of 24.7%. Currently, TransMedics Gr has a market ...

On Wednesday, Needham reiterated its Hold rating on TransMedics Group (NASDAQ:TMDX), following management's growth strategy update. The stock, which has seen a significant decline ...